Skip to the main content.
Login Contact us
shine-bright-diamond-lung
Lung_Logo.e69fd6fe

by Arterys®

 

AI gets real.
Your AI-Assisted Chest CT Analysis Software.


Lung AI helps physicians detect, measure, and longitudinally track lung nodules with automated scoring, worklist prioritization, and intelligent analysis/reporting.

1396637_Arterys - Lung AI Images & Gifs_Stock Img27 GIF_062822

Improve Efficiency

 

Save time with automated measured segmentations, longitudinal tracking, and customizable reporting

Consistent Results

 

Increase inter-radiologist agreement for study-level nodule presence with robust, reproducible and standardized reporting

Improve Accuracy

 

Reduce the rate of missed nodule detections with easy-to-interpret automated analysis and customizable reporting

Optimized Workflow

 

Anytime, anywhere, access, seamless integration with existing PACS, EHR, worklist, notification, and dictation systems

Ease of Integration

 

One integration and user interface to gain access to all AI and images with no app switching cost

Nodule Detection

 

Automatic detection of solid, part solid, and ground glass nodules. Our interactive workflow allows the user to add, edit, or delete detections with automatic updates to quantitative information.

Lung nodule detection is CE-marked, and FDA cleared and powered by Infervision

1396637_Arterys - Lung AI Images & Gifs_Stock Img24_5_062722
 

Notifications

 

Customizable messages into worklists providing prioritization and exam insights. Automatic Study Flagging

1396637_Arterys - Lung AI Images & Gifs_Stock Img1_2_062022
 

Intelligent Analysis and Reporting


Automated, single-click nodule segmentation and real-time updates to quantitative measurements for segmentation edits. The long axis, short axis, volume, Hounsfield units, and comparison values are calculated and displayed. Nodule information is included in reporting with configurable integration options

1396637_Arterys - Lung AI Images & Gifs_Stock Img15_8_062322
 

Scoring

 

A dedicated scoring panel for screening examinations to assign Fleischner - Lung- RADS criteria that captures key calculations and comparative values between studies. Users have the ability to change baseline exam date for more accurate recommendations of characteristic changes

iPad Pro in the hands of a woman_image (1)-1-2
 

Longitudinal Tracking


Whether you have one or many studies to compare, Arterys has your back. Automatically longitudinally track lung nodules across multiple exams over time with tabular and graphical progression. Quantification of nodule progression with key metrics of nodule changes over time.

MacBook Pro in hands of an African-American woman_Prior Study Viewing
 

Learn more about Lung AI

Speak with an Arterys expert about how Lung AI can help your team achieve fast, consistent results within your current workflow.

 

Schedule a Demo

Share the Arterys Lung AI solution with your colleagues by downloading the brochure.

Lung AI Sell Sheet Image-1

 

More Lung AI information from the Arterys Blog

Fleischner Society Shines Spotlight On AI's Benefit To Lung CT Radiology

The Fleischner Society, a multidisciplinary alliance for thoracic radiology, just held its 53rd annual meeting in...

Lung AI Solution Is A Powerful, Fast And Reliable Second Opinion

Arterys' Lung AI solution helps physicians analyze and track lung nodules by automatically processing Lung CT scans to...

Lung AI Solution Proves Quick and Reliable in Nodule Detection

Discover through a Radiologists' clinical experience how Lung AI helps physicians analyze and track lung nodules by...

Arterys has joined Tempus, and we are excited to reintroduce ourselves to you as Tempus Radiology.
Tempus is a leading technology company that is advancing precision medicine through the practical application of data and artificial intelligence in healthcare. By joining forces, Arterys’ product will be integrated into Tempus’ solutions, enabling providers to access a comprehensive patient view (now inclusive of radiology scans) and researchers to leverage this new data modality to optimize the drug development process.